Weiyan Cheng
Impact in
-
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in
-
- Protein Degradation and Inhibitors 3
- Ubiquitin and proteasome pathways 3
- Oncology 10
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Xin Tian (11 shared papers)Xiaojian Zhang (9 shared papers)Wei Han (6 shared papers)Zhiheng Yang (7 shared papers)Suhua Wang (4 shared papers)Yueqin Wang (3 shared papers)Quancheng Kan (2 shared papers)Ying Li (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry (3 papers)Current Medicinal Chemistry (2 papers)Bioorganic Chemistry (2 papers)Sensors and Actuators B Chemical (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Weiyan Cheng
23 papers receiving 489 citations
Peers
Comparison fields: 5 of 71
- Molecular Medicine 30
- Oncology 144
- Molecular Biology 304
- Process Chemistry and Technology 12
- Organic Chemistry 113
Countries citing papers authored by Weiyan Cheng
This map shows the geographic impact of Weiyan Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyan Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyan Cheng more than expected).
Fields of papers citing papers by Weiyan Cheng
This network shows the impact of papers produced by Weiyan Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyan Cheng. The network helps show where Weiyan Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiyan Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 84 | |
| 2 | 2019 | 83 | |
| 3 | 2019 | 49 | |
| 4 | 2021 | 37 | |
| 5 | 2016 | 32 | |
| 6 | 2017 | 29 | |
| 7 | 2014 | 26 | |
| 8 | 2020 | 23 | |
| 9 | 2014 | 21 | |
| 10 | 2023 | 19 | |
| 11 | 2018 | 17 | |
| 12 | 2019 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 2016 | 12 | |
| 15 | 2014 | 9 | |
| 16 | 2019 | 8 | |
| 17 | 2021 | 6 | |
| 18 | 2022 | 4 | |
| 19 | 2023 | 4 | |
| 20 | 2011 | 3 |
About Weiyan Cheng
Weiyan Cheng is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Organic Chemistry, having authored 25 papers that have together received 499 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), HER2/EGFR in Cancer Research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Treatment and Pharmacology (2 papers), Quinazolinone synthesis and applications (2 papers) and Chemical Reactions and Isotopes (2 papers). The work is most often cited by research in Molecular Medicine (30 citations), Oncology (144 citations), Molecular Biology (304 citations), Process Chemistry and Technology (12 citations) and Organic Chemistry (113 citations). Weiyan Cheng has collaborated with scholars based in China and United States. Frequent co-authors include Xin Tian, Xiaojian Zhang, Wei Han, Zhiheng Yang, Suhua Wang, Yueqin Wang, Quancheng Kan, Ying Li, Yongzhou Hu and Shasha Li. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Current Medicinal Chemistry, Bioorganic Chemistry and Sensors and Actuators B Chemical.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.